Landstar System (NASDAQ:LSTR): Wunderlich reiterated its rating of Hold for this company and changed its price target from $56 to $54. Dahlman Rose reiterated its rating of Buy for this company and changed its price target from $56 to $54.

Bio-Reference Labs (NASDAQ:BRLI): The Benchmark Company reiterated its rating of Buy for this company and changed its price target from $27 to $30.

Zumiez (NASDAQ:ZUMZ): Janney Mntgmy Scott reiterated its rating of Neutral for this company and changed its price target from $36 to $29.